Cancer Risk clinical trials at UCSF

1 research study open to eligible people

Cancer risk is the probability of developing the disease. UCSF is investigating the effectiveness of MRI scans combined with AI in spotting breast cancer. This study focuses on enhancing detection methods to identify cancer sooner in people who might be at higher risk.

Showing trials for

  • Mirai-MRI: Validation of AI Models for Breast Cancer Risk

    open to eligible females ages 40-89

    This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.

    San Francisco, California and other locations

Our lead scientists for Cancer Risk research studies include .

Last updated: